Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -NZ$0.8 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -NZ$0.8 B. In 2023 the company made an earning of -NZ$0.78 B an increase over its 2022 earnings that were of -NZ$1.06 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.8 B3.34%
2023 -NZ$0.78 B-26.73%
2022 -NZ$1.06 B69.96%
2021 -NZ$0.63 B56.35%
2020 -NZ$0.4 B252.69%
2019 -NZ$0.12 B-17.22%
2018 -NZ$0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.47 B-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$23.13 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA